Dr Reddys Laboratories Share Price Today - Live Blog for July 24, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.15%, reaching the current market price of ₹1,266.25. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,266.25. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.35% decline, and it currently trades at ₹1,265.40 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd shares experienced a -0.35% reduction, with the current market price at ₹1,265.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.21%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,270.70, and market participants are assessing the implications. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.16% decrease, reaching a current market price of ₹1,273.35. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.23%, signalling a challenging period. Currently trading at ₹1,275.10, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,278.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd shares saw a -0.12% decrease, reaching a current market price of ₹1,279.40. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.01% recently. As of now, this stock is actively trading at a current market price of ₹1,279.65 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,280.55. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a -0.01% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,282.00. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% decline, and it currently trades at ₹1,282.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

After a notable 0.16% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,279.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd witnessed a substantial 0.16% increase in its share price and is currently trading at ₹1,279.00. This remarkable performance has caught the eye of investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.07%. At this moment, it's actively trading at ₹1,277.70, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,277.85, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.14% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,277.45. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.4100, while the industry PE is 35.4957.

Dr Reddys Laboratories Ltd's share price has dropped by -0.16%, a development that warrants careful analysis. Presently trading at ₹1,279.50, investors are assessing whether this presents an opportunity or a risk.

After a significant 0.20% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,280.60 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,277.50. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.05% increase and currently trading at ₹1,276.90 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd share price has declined by -0.55%, and it's currently trading at ₹1,264.85. The stock maintains a PE of 18.4100, while the industry PE is 35.4957, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.55% drop, and it's now trading at ₹1,264.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.91% drop, and it's now trading at ₹1,270.55 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.79% recently. As of now, this stock is actively trading at a current market price of ₹1,255.05 per share, attracting attention from investors.